Select Medical Completes Acquisition, Ceases Trading
Select Medical announced the completion of its acquisition by an entity affiliated with a consortium led by Robert Ortenzio, Executive Chairman, Co-Founder and Director of Select Medical, Martin Jackson, Senior Executive Vice President of Strategic Finance and Operations of Select Medical, and Welsh, Carson, Anderson & Stowe, pursuant to the terms of the Agreement and Plan of Merger, dated as of March 2. The company filed a Certificate of Merger, pursuant to which the acquisition will become effective as of July 1 at 12:01 am. With the completion of the acquisition, Select Medical's common stock will cease trading and Select Medical will no longer be listed on the New York Stock Exchange as of July 1. The Consortium maintains effective and operational control of the company and its subsidiaries and now has a majority of the economic interest in the company.